Wedbush Securities’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,011
| Closed | -$214K | – | 1227 |
|
|
2021
Q4 | $214K | Sell |
6,011
-3,495
| -37% | -$124K | 0.01% | 1037 |
|
|
2021
Q3 | $390K | Buy |
+9,506
| New | +$390K | 0.02% | 722 |
|
|
2020
Q4 | – | Sell |
-13,924
| Closed | -$385K | – | 1006 |
|
|
2020
Q3 | $385K | Buy |
13,924
+4,984
| +56% | +$138K | 0.04% | 510 |
|
|
2020
Q2 | $255K | Buy |
+8,940
| New | +$255K | 0.02% | 667 |
|